Abstract
BackgroundIn the USA, colorectal cancer is among the top diagnosed cancers. The current study specifically targets the US adult population that have a history of colorectal cancer.MethodsWe used the 2017 National Health Interview Survey (NHIS) to investigate the prevalence and predictors of colorectal cancer survivors using complementary medicine in the past 12 months in a representative sample of the US population (N = 26,742). We descriptively analyzed the 12-month prevalence of any complementary medicine use separately for individuals with a prior diagnosis of colorectal cancer and those without. Using chi-squared tests and backward stepwise multiple logistic regression analyses, we identified predictors of complementary medicine use in the past 12 months.ResultsA weighted total of 1,501,481 US adults (0.6%) had a history of colorectal cancer. More individuals without (weighted n = 76,550,503; 31.2%) than those with a history of colorectal cancer (weighted n = 410,086; 27.3%) had used complementary medicine. The most commonly used complementary medicine among colorectal cancer patients was mind-body medicine, followed by chiropractic. A higher prevalence of complementary medicine use was associated with being female, higher educated and/or living in the US Midwest or South.ConclusionsIn this study, over one fourth of the US colorectal cancer survivors had used complementary medicine. Mind-body medicine was found to be the most commonly used. With evidence supporting the effectiveness and safety of mind-body medicine use among colorectal cancer patients, promoting the use of evidence-based mind-body medicine for colorectal cancer management could be considered.
Highlights
The populations of North America, along with those in Europe, Australia, New Zealand, and Eastern Asia, have the highest age standardized incidence rates of colorectal cancer in the world [1]
Considering the variation of the incidence of colorectal cancer between different regions and cultures, factors that may contribute to the expected increase are the economical and developmental changes in many lowand middle-income countries including the adoption of western lifestyle [4]
We found that a weighted total of 1,501,481 US adults (0.6%) had a history of colorectal cancer
Summary
The populations of North America, along with those in Europe, Australia, New Zealand, and Eastern Asia, have the highest age standardized incidence rates of colorectal cancer in the world [1]. The lifetime risk of US men and women of developing colorectal cancer has been estimated to 4.2% [3]. It has been estimated that the global burden of colorectal cancer will grow by 60% over the decade to encompass more than 2.2 million new cases and 1.1 million deaths by 2030 [4]. Considering the variation of the incidence of colorectal cancer between different regions and cultures, factors that may contribute to the expected increase are the economical and developmental changes in many lowand middle-income countries including the adoption of western lifestyle [4]. The current study targets the US adult population that have a history of colorectal cancer
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
